LifeMD, Inc.
NASDAQ:LFMDMedical - Pharmaceuticals
-$0.16 today
- Market cap
- $82.17M
- Beta
- 1.99
- P/E (TTM)
- -13.8
- EPS (TTM)
- -$0.34
Volume 0.80M
Average 1.04M
LFMD Common Stock Issued
Cash raised by issuing new shares.
LifeMD, Inc.NASDAQ: LFMD
Common Stock Issued · Q1 FY2026 · quarter ended Mar 2026
Common stock issued outflow grows to $80.52K
Q1 FY2026 common stock issued was $80.52K, compared with $0 a year earlier. Trailing-twelve-month common stock issued was $9.27M.
Context
- Common stock issued amounted to 4.7% of revenue in FY2025, up 4.7 pp from a year earlier.
- Common stock issued increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly common stock issued holds near $80.52K or moves back toward the trailing-twelve-month quarterly average of $2.32M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Issued history
USD · from the cash flow
- Latest · FY2025
- 9.19M USD
- Year-over-year change
- —
- 4-year CAGR
- -10.0%
| Period | Period end | Common Stock Issued | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 9.19M | — |
| FY2024 | 2024-12-31 | 0 | -100.0% |
| FY2023 | 2023-12-31 | 16.2M | — |
| FY2022 | 2022-12-31 | 0 | -100.0% |
| FY2021 | 2021-12-31 | 13.99M | — |
Common Stock Issued vs competitors
How LFMD compares with its peers on the latest reported figures
- Peers report in different currencies, so common stock issued is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +74091.0% is the highest of 8, against a peer median of -64.5%.
- Common stock issued amounts to 4.2% of revenue for LFMD, versus a peer median of 0.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $77.69M USD | +73.3% | +43.4% | 190.8% | |
| LTM Mar 2026 | $9.27M USD | +74091.0% | — | 4.2% | |
| LTM Mar 2026 | $1.89M USD | +90.0% | +14.0% | 2.4% | |
| LTM Mar 2026 | $937K USD | -97.7% | +139.0% | 1.6% | |
| LTM Mar 2026 | $932K USD | -15.0% | -17.8% | 1.6% | |
| LTM Apr 2026 | CA$432.57K CAD | -88.3% | -69.4% | 0.1% | |
| LTM Mar 2026 | $211K USD | -64.5% | — | 0.1% | |
| LTM Mar 2026 | $144K USD | -99.1% | -21.7% | 0.3% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding LFMD) | — | -64.5% | -1.9% | 0.3% | |
Competitors are the stored peer set for LFMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (61.32M) | (45.02M) | (20.6M) | (18.73M) | 15.62M |
| Depreciation & Amortization | 868.76K | 3.77M | 6.6M | 9.49M | 328.37K |
| Deferred Income Tax | 0 | 354K | 0 | 0 | 0 |
| Stock-Based Compensation | 12.07M | 13.73M | 12.49M | 12.23M | 10.5M |
| Change in Working Capital | 9.13M | (1.55M) | 4.91M | 12.65M | (7.85M) |
| Accounts Receivables | 17.7K | (2.19M) | (2.44M) | (2.94M) | 1.15M |
| Inventory | (409.82K) | (2.18M) | 764.33K | 675.67K | 303.24K |
| Accounts Payables | (893.96K) | 1.25M | 978.06K | 4.92M | 3.24M |
| Other Working Capital | 10.42M | 1.58M | 5.61M | 9.99M | (12.55M) |
| Other Non-Cash Items | 6.17M | 5.78M | 5.42M | 1.87M | (10.31M) |
| Operating Cash Flow | (33.09M) | (22.94M) | 8.82M | 17.51M | 8.28M |
| Capital Expenditures | (3.4M) | (12.89M) | (8.73M) | (11.54M) | (9.52M) |
| Acquisitions (Net) | 0 | (1.01M) | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (3.15M) | (12.53M) | (8.53M) | (10.05M) | 8.78M |
| Investing Cash Flow | (3.4M) | (13.91M) | (8.73M) | (11.54M) | 6.91M |
| Debt Repayment | (530.82K) | 2.74M | 16.67M | (327.6K) | (18.72M) |
| Common Stock Issued | 13.99M | 0 | 16.2M | 0 | 9.19M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | (871.48K) | (3.11M) | (3.11M) | (3.11M) | (3.11M) |
| Other Financing Activities | 707.36K | (159.2K) | (667.63K) | (684.83K) | (773.66K) |
| Financing Cash Flow | 68.64M | (528.2K) | 29.1M | (4.12M) | (13.41M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 32.15M | (37.37M) | 29.19M | 1.86M | 1.78M |
| Free Cash Flow | (36.49M) | (35.83M) | 86.95K | 5.98M | (1.24M) |
LifeMD, Inc.
NASDAQ:LFMD
Intrinsic Alpha fair value
Locked
Current Price
$1.70
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.